Ponesimod to treat multiple sclerosis.
Sign Up to like & getrecommendations! Published in 2021 at "Drugs of today"
DOI: 10.1358/dot.2021.57.12.3353166
Abstract: Ponesimod (ACT-128800) is a directly bioavailable, rapidly reversible sphingosine-1-phosphate (S1P) receptor modulator, highly selective for the subtype 1 (S1P₁ receptor). It acts by blocking the egress of lymphocytes from the lymphoid organs, thus limiting the… read more here.
Keywords: ponesimod; treat multiple; ponesimod treat; multiple sclerosis ... See more keywords